Evidence-based selection of the starting dose in first-in-human clinical trials using humanized mouse models
The dose selection for first-in-human (FIH) clinical trials relies on data obtained by a combination of in vitro and in vivo studies designed to evaluate the efficacy, toxicity, and stability of...
Learn More